NUMAFERM GmbH was founded in 2017 as a spin-off of the Biochemistry Institute at the Heinrich-Heine University, Dusseldorf. The project was previously supported by an EXIST research transfer from the German Federal Ministry of Economics and Energy. The company offers its technology, related R&D services and a peptide catalogue focusing on pharmaceutical, antimicrobial and adhesives peptides.

Press releases

Full speed ahead in the same boat – A talk about Simplaex and Numaferm’s cooperation

Let’s be honest, for a seed investor like HTGF, it’s great when portfolio companies connect and then go on to work together. And that’s exactly what happened with digital agency Ogno, a product of Simplaex, and life sciences company Numaferm. We sat down for a chat…

Evonik is investing in NUMAFERM, a specialist in the biotechnological production of peptides

NUMAFERM makes the production of peptides more efficient Investment strengthens Evonik’s growth engines Health & Care and Specialty Additives at Evonik New technical applications are becoming realistic for the first time Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now…

NUMAFERM revolutionizes peptide production and receives seed financing

The Dusseldorf university spin-off NUMAFERM specializes in the biotechnical production of peptides and is able, through its newly developed platform technology, to dramatically reduce costs for this raw material. For the further technological development and an accelerated market entry, NUMAFERM GmbH is now receiving…

Info & Contact

Dr. Christian Schwarz


Merowingerplatz 1a
40225 Düsseldorf

In portfolio

28. Apr 2017